Alkermes ALKS
NASDAQ ALKS
$45.38 -0.12 (-0.25%)
As of: Sep 9, 2026 · 3:27 PM EDT

Alkermes (ALKS) Cash from Operations (2010 - 2026)

Alkermes' (ALKS) quarterly Cash from Operations came in at $145.2 million in Q2 2026, down 3.34% year-over-year from $150.2 million in Q2 2025, and up 187.6% quarter-over-quarter from -$165.7 million in Q1 2026.

Analysis

Alkermes (ALKS) Cash from Operations (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Cash from Operations for 17 consecutive years, with $145.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Operations fell 3.34% year-over-year to $145.2 million in Q2 2026; TTM through Jun 2026 was $251.2 million, a 51.79% decrease from a year earlier, with the FY2025 full-year figure at $520.8 million, up 18.59% from the prior year.
  • Cash from Operations was $145.2 million for Q2 2026 at Alkermes, up from -$165.7 million in the prior quarter.
  • Over five years, Cash from Operations peaked at $215.7 million in Q2 2023 and troughed at -$165.7 million in Q1 2026.
  • A 5-year average of $75.7 million and a median of $99.3 million in 2023 frame the typical range for Cash from Operations.
  • Across the five-year window, Cash from Operations surged 15853.28% in 2023 and plunged 267.74% in 2026, its largest moves.
  • Over 5 years, Cash from Operations stood at $1.0 million in 2022, then jumped by 10142.31% to $107.2 million in 2023, then surged by 77.55% to $190.4 million in 2024, then slipped by 10.68% to $170.1 million in 2025, then retreated by 14.63% to $145.2 million in 2026.
  • The last three Cash from Operations figures came in at $145.2 million (Q2 2026), -$165.7 million (Q1 2026), and $170.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Johnson & Johnson 645.93 Bn 625.17 Bn 17.26 Bn 8.62 Bn
2 AbbVie 443.06 Bn 436.49 Bn 12.70 Bn 3.44 Bn
3 Merck 365.76 Bn 358.62 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 266.47 Bn 258.78 Bn 11.24 Bn 5.88 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 835.00 Mn
6 Sanofi 52.36 Bn 44.98 Bn 10.79 Bn 3.44 Bn
7 Revolution Medicines 43.97 Bn 43.97 Bn - -387.32 Mn
8 Incyte 25.42 Bn 20.88 Bn 1.57 Bn 507.66 Mn
9 United Therapeutics 21.52 Bn 18.86 Bn 683.80 Mn 313.60 Mn
10 Alkermes 7.58 Bn 6.93 Bn 397.90 Mn 145.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 145.18 Mn
Mar 31, 2026 -165.74 Mn
Dec 31, 2025 170.07 Mn
Sep 30, 2025 101.67 Mn
Jun 30, 2025 150.20 Mn
Mar 31, 2025 98.81 Mn
Dec 31, 2024 190.40 Mn
Sep 30, 2024 81.59 Mn
Jun 30, 2024 146.03 Mn
Mar 31, 2024 21.11 Mn
Dec 31, 2023 107.24 Mn
Sep 30, 2023 99.71 Mn
Jun 30, 2023 215.71 Mn
Mar 31, 2023 -21.30 Mn
Dec 31, 2022 1.05 Mn
Sep 30, 2022 625,000.00
Jun 30, 2022 -2.31 Mn
Mar 31, 2022 21.68 Mn
Dec 31, 2021 31.02 Mn
Sep 30, 2021 82.78 Mn